Insider Trading & Ownership of BVF PARTNERS L P/IL

Location
San Francisco, CA
Summary
The estimated value of insider holdings of BVF PARTNERS L P/IL is at least $163,361,343 dollars as of 30 Jan 2026. BVF PARTNERS L P/IL is the 10%+ Owner of XOMA Royalty Corp and owns shares of XOMA Royalty Corp (XOMA) stock worth about $63.49M. BVF PARTNERS L P/IL is the Director, 10%+ Owner of MoonLake Immunotherapeutics and owns shares of MoonLake Immunotherapeutics (MLTX) stock worth about $52.01M. BVF PARTNERS L P/IL is the Director, Other* of Kymera Therapeutics, Inc. and owns shares of Kymera Therapeutics, Inc. (KYMR) stock worth about $17.76M. BVF PARTNERS L P/IL is the 10%+ Owner of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $10.89M. BVF PARTNERS L P/IL is the 10%+ Owner of Merus N.V. and owns shares of Merus N.V. (MRUS) stock worth about $6.47M. BVF PARTNERS L P/IL is the Director, Other* of Olema Pharmaceuticals, Inc. and owns shares of Olema Pharmaceuticals, Inc. (OLMA) stock worth about $3.72M. BVF PARTNERS L P/IL is the 10%+ Owner of Eledon Pharmaceuticals, Inc. and owns shares of Eledon Pharmaceuticals, Inc. (ELDN) stock worth about $3.63M. BVF PARTNERS L P/IL is the Other* of Third Harmonic Bio, Inc. and owns shares of Third Harmonic Bio, Inc. stock worth about $2.53M. BVF PARTNERS L P/IL is the Other* of 4D Molecular Therapeutics, Inc. and owns shares of 4D Molecular Therapeutics, Inc. (FDMT) stock worth about $1.44M. BVF PARTNERS L P/IL is the 10%+ Owner of Cullinan Oncology, Inc. and owns shares of Cullinan Therapeutics, Inc. (CGEM) stock worth about $799.4K. BVF PARTNERS L P/IL is the Other* of PIERIS PHARMACEUTICALS, INC. and owns shares of PALVELLA THERAPEUTICS, INC. (PVLA) stock worth about $618.8K. BVF PARTNERS L P/IL is the 10%+ Owner of CRESCENT BIOPHARMA, INC. and owns shares of CRESCENT BIOPHARMA, INC. (CBIO) stock worth about $15.6K.
Signature
BVF Partners L.P., By: BVF Inc., its general partner, By: /s/ Mark N. Lampert, President
All Insider Reports
All Insider Reports

Notify me when BVF PARTNERS L P/IL files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of BVF PARTNERS L P/IL

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
XOMA, XOMAO XOMA Royalty Corp 10%+ Owner $63,488,709 -$10,642,793 -14% 16 May 2025
MLTX MoonLake Immunotherapeutics Director, 10%+ Owner $52,011,000 05 Jun 2025
KYMR Kymera Therapeutics, Inc. Director, Other* $17,761,268 +$13,955,348 +367% 25 Jun 2025
VSTM Verastem, Inc. 10%+ Owner $10,888,165 25 Jan 2022
MRUS Merus N.V. 10%+ Owner $6,467,225 07 Oct 2021
OLMA Olema Pharmaceuticals, Inc. Director, Other* $3,716,633 11 Jun 2025
ELDN Eledon Pharmaceuticals, Inc. 10%+ Owner $3,632,225 29 Oct 2024
THRD Third Harmonic Bio, Inc. Other* $2,526,696 29 Oct 2024
FDMT 4D Molecular Therapeutics, Inc. Other* $1,435,587 08 Nov 2024
CGEM Cullinan Oncology, Inc. 10%+ Owner $799,446 19 Jan 2023
PVLA PIERIS PHARMACEUTICALS, INC. Other* $618,794 13 Dec 2024
CBIO CRESCENT BIOPHARMA, INC. 10%+ Owner $15,595 13 Jun 2025
ALLK Allakos Inc. 10%+ Owner $0 15 May 2025
EPIX ESSA Pharma Inc. 10%+ Owner $0 -$293 -100% 09 Oct 2025
RAIN Rain Oncology Inc. Director, Other* $0 25 Jan 2024
RPTX Repare Therapeutics Inc. 10%+ Owner $0 28 Jan 2026
CTIC CTI BIOPHARMA CORP Director, Other*, 10%+ Owner 26 Jun 2023
ENGN, ENGNW enGene Holdings Inc. 10%+ Owner 31 Oct 2023
PNT POINT Biopharma Global Inc. Former 10% Owner 18 Dec 2023
GPCR Structure Therapeutics Inc. 10%+ Owner 10 May 2023

Insider Transactions Reported by BVF PARTNERS L P/IL:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.